Artykuły udostępnione publicznie: - Andre KalilWięcej informacji
Niedostępne w żadnym miejscu: 8
Sepsis in immunocompromised patients without human immunodeficiency virus
RJ McCreery, DF Florescu, AC Kalil
The Journal of Infectious Diseases 222 (Supplement_2), S156-S165, 2020
Upoważnienia: Gordon and Betty Moore Foundation
Ceftazidime-avibactam versus meropenem for the treatment of nosocomial pneumonia
AC Kalil, M Klompas
The Lancet Infectious Diseases 18 (3), 229-231, 2018
Upoważnienia: US National Institutes of Health, UK Medical Research Council, Wellcome …
Is the evidence for benefits from ventilator-associated pneumonia bundles reliable enough for implementation in a general hospital?
AC Kalil, JP Wiener-Kronish
Critical care medicine 40 (1), 348-350, 2012
Upoważnienia: US National Institutes of Health
Convalescent plasma and coronavirus disease 2019: time for reassessment
DA Sweeney, CA Benson, AC Kalil
Critical care medicine 49 (7), 1182-1186, 2021
Upoważnienia: US National Institutes of Health
Emergence of Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae Colonization: What Termites Can Teach Us About the Gut Microbiota
DA Sweeney, AC Kalil
Critical care medicine 45 (4), 752-754, 2017
Upoważnienia: Canadian Institutes of Health Research
Baricitinib or Tocilizumab? Treatment of Patients Hospitalized With Severe COVID-19
KA Cawcutt, AC Kalil
Critical care medicine 51 (3), 413-415, 2023
Upoważnienia: US National Institutes of Health
Remdesivir for the Treatment of Covid-19--Preliminary Report.
M Durrani, A Khan, JH Beigel, KM Tomashek, LE Dodd, AK Mehta, ...
Ophthalmology Update 18 (3), 2020
Upoważnienia: US National Institutes of Health
Daily emtricitabine plus tenofovir disoproxil fumarate reduced risk for HIV infection in men who have sex with men
AC Kalil, US Sandkovsky
Annals of internal medicine 154 (16), JC4-2, 2011
Upoważnienia: US National Institutes of Health
Dostępne w jakimś miejscu: 52
Remdesivir for the treatment of Covid-19
JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ...
New England Journal of Medicine 383 (19), 1813-1826, 2020
Upoważnienia: US Department of Defense, US National Institutes of Health, US Department of …
Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the …
AC Kalil, ML Metersky, M Klompas, J Muscedere, DA Sweeney, ...
Clinical infectious diseases 63 (5), e61-e111, 2016
Upoważnienia: US National Institutes of Health, US Department of Veterans Affairs
Baricitinib plus remdesivir for hospitalized adults with Covid-19
AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ...
New England Journal of Medicine 384 (9), 795-807, 2021
Upoważnienia: US Department of Defense, US National Institutes of Health, US Department of …
The use of TKM-100802 and convalescent plasma in 2 patients with Ebola virus disease in the United States
CS Kraft, AL Hewlett, S Koepsell, AM Winkler, CJ Kratochvil, LA Larson, ...
Clinical Infectious Diseases 61 (4), 496-502, 2015
Upoważnienia: US National Institutes of Health
Association of hearing impairment with incident frailty and falls in older adults
RJ Kamil, J Betz, BB Powers, S Pratt, S Kritchevsky, HN Ayonayon, ...
Journal of aging and health 28 (4), 644-660, 2016
Upoważnienia: US National Institutes of Health, US Department of Veterans Affairs
Infectious Diseases Society of America (IDSA) position statement: why IDSA did not endorse the surviving sepsis campaign guidelines
IDSA Sepsis Task Force Kalil Andre C Gilbert David N Winslow Dean L Masur ...
Clinical Infectious Diseases 66 (10), 1631-1635, 2018
Upoważnienia: US National Institutes of Health
O-GlcNAc transferase suppresses inflammation and necroptosis by targeting receptor-interacting serine/threonine-protein kinase 3
X Li, W Gong, H Wang, T Li, KS Attri, RE Lewis, AC Kalil, F Bhinderwala, ...
Immunity 50 (3), 576-590. e6, 2019
Upoważnienia: US National Institutes of Health
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
P Póvoa, L Coelho, F Dal-Pizzol, R Ferrer, A Huttner, A Conway Morris, ...
Intensive care medicine 49 (2), 142-153, 2023
Upoważnienia: UK Medical Research Council
Infectious Diseases Society of America position paper: recommended revisions to the national severe sepsis and septic shock early management bundle (SEP-1) sepsis quality measure
C Rhee, K Chiotos, SE Cosgrove, EL Heil, SS Kadri, AC Kalil, DN Gilbert, ...
Clinical Infectious Diseases 72 (4), 541-552, 2021
Upoważnienia: US National Institutes of Health
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial
AC Kalil, AK Mehta, TF Patterson, N Erdmann, CA Gomez, MK Jain, ...
The lancet respiratory medicine 9 (12), 1365-1376, 2021
Upoważnienia: US Department of Defense, US National Institutes of Health, US Department of …
Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study
B Mehta, S Pedro, G Ozen, A Kalil, F Wolfe, T Mikuls, K Michaud
RMD open 5 (1), e000935, 2019
Upoważnienia: US National Institutes of Health
New filovirus disease classification and nomenclature
JH Kuhn, T Adachi, NKJ Adhikari, JR Arribas, IE Bah, DG Bausch, ...
Nature Reviews Microbiology 17 (5), 261-263, 2019
Upoważnienia: US Department of Energy, US National Institutes of Health, Government of Italy
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy